Researchers at Massachusetts General Hospital have developed a novel CAR T-cell construct that targets acute myeloid leukemia (AML) effectively. The combination of drug therapy and engineering approaches enhanced the treatment's ability to adhere to tumor cells, overcoming previous difficulties with antigen targeting.
Researchers have identified helpful and unhelpful aspects of the immune response that determine whether TB infections can be kept under control. The findings may help design a more effective vaccine by targeting specific cell subsets and modulating intercellular signaling.
A team of researchers has identified two transcription factors, AP-2α and AP-2β, that regulate distinct segments of the distal nephron in the mammalian kidney. The study sheds light on the molecular mechanisms underlying urinary concentration and its implications for treating kidney diseases.
A study published in Nature Neuroscience found that hydrocephalus is caused by problems with brain stem cells, not fluid circulation. Genetic analysis identified a key gene mutation, TRIM71, which disrupts neuroepithelial cell development, leading to underdeveloped brains and cerebral cortex compression.
A new study from Massachusetts General Hospital reveals a strong association between infertility and an increased risk of heart failure, particularly in women. Infertility was associated with a 16% increased risk of overall heart failure and a 27% increased risk of HFpEF.
A phase 1–2 clinical trial led by Massachusetts General Hospital has shown promising safety and efficacy results for rilzabrutinib, an oral Bruton kinase inhibitor, in treating immune thrombocytopenia. The study found that 40% of patients experienced a significant platelet response, with minimal treatment-related adverse events.
Researchers developed mitapivat to target pyruvate kinase deficiency, a rare genetic condition leading to hemolytic anemia. The Phase 3 clinical trial showed significant improvements in hemoglobin levels and quality of life for patients with the disorder.
Researchers at Massachusetts General Hospital identified genes that play a crucial role in maintaining healthy kidney repair, including FANCD2 and Rad51. Activating a DNA repair mechanism may help preserve kidney function in people with chronic kidney disease.
A phase I clinical trial demonstrated the safety and efficacy of a novel adeno-associated viral vector-based treatment for HIV, producing measurable amounts of a broadly neutralizing antibody. The treatment showed wide-ranging clinical implications for potentially preventing or treating HIV and other infections.
Research reveals that imbalances in the intestine's viral community may promote inflammatory bowel disease. Viruses in a normal intestine have anti-inflammatory effects, whereas those from inflamed intestines provoke inflammation. This study provides a missing functional link between the virome and human health.
Despite increasing racial and ethnic diversity, US academic medical programs have underrepresented minority groups, with only modest increases in representation over the past four decades. Female representation has increased significantly, but progress in promoting diversity at leadership levels remains stagnant.
Researchers found that non-English speaking patients had a 35% greater risk of dying or requiring ICU support compared to English-speaking patients. Hospitals can address language disparities through improved communication, interpreter availability, and translated materials.
A clinical trial reveals that lamivudine, a widely used HIV treatment, halted disease progression in 28% of patients with fourth-line metastatic colorectal cancer. The study suggests an unexpected promising direction for cancer treatment and encourages the exploration of pairing reverse transcriptase inhibitor therapy with immunotherapy.
Researchers at Massachusetts General Hospital have discovered that certain RNA molecules called tDRs released by cells in response to stress can serve as markers of cellular stress in different diseases. The study created an atlas of stress signatures for tDRs, which can be used to diagnose and understand various conditions.
Researchers at Massachusetts General Hospital have discovered a new class of biological factors that can be targeted by small molecule drugs, including noncoding RNAs. This breakthrough could lead to new therapies for genetic disorders such as Rett syndrome and Fragile X syndrome.
A new study published in Nature Immunology finds that B cells produce the neurotransmitter acetylcholine, which blocks white blood cell production and reduces cardiovascular inflammation. This discovery may lead to new treatments for conditions such as atherosclerosis and heart failure.
A large study published in JAMA Network Open found no evidence that light alcohol consumption provides heart-related health benefits, instead suggesting lifestyle factors common among moderate drinkers contribute to the observed benefit. The study linked high-risk cardiovascular disease across all levels of alcohol intake.
Researchers at Massachusetts General Hospital discovered that non-dividing colon cancer cells employ Warburg glycolysis to reduce toxic reactive oxygen species accumulation. This adaptation challenges the long-held dogma of the Warburg effect, highlighting the need for single-cell level analysis tools.
A new study published in Tobacco Control found that cities banning flavored tobacco sales have reduced youth tobacco use, particularly vaping and cigarette smoking. In contrast to a previous study, the new analysis supports a ban on flavored tobacco products as an effective measure to prevent adolescent tobacco use.
Researchers have found that immune checkpoint inhibitors like pembrolizumab can slow disease progression in patients with high-grade meningiomas. The study showed that nearly half of all patients were alive and without evidence of disease progression for at least 6 months after treatment.
Researchers at Massachusetts General Hospital have found that cancer cells expressing certain kinases are more responsive to targeted therapies. These findings may help tailor treatments to individual patients based on the specific types and levels of protein expression in their tumors.
Researchers at Massachusetts General Hospital found that medical marijuana users were more likely to develop cannabis use disorder (CUD) than expected, particularly those seeking relief from anxiety and depression. The study suggests that the current system of dispensing and using medical marijuana may be contributing to this issue.
A new survey conducted by Massachusetts General Hospital researchers reveals that medical students, residents, and fellows do not see themselves as innovators. The study identifies key impediments to innovation, such as limited time and energy, lack of physical resources, and expertise gaps, but also highlights potential solutions like...
Scientists identified neurons in mice brains that influence competitive interactions and shape group social behavior. The study provides new insights into human interactions and advances research related to neurocognitive conditions such as autism spectrum disorder.
Researchers at Massachusetts General Hospital have found that specific proteins surrounding organs and tissues can suppress natural killer cell function. Blocking these interactions could potentially reactivate the cells, providing a new strategy for treating various health conditions, including cancer, autoimmune diseases, and inflamm...
Researchers found that sequencing drug combinations can enhance the anti-tumor immune response in liver cancer, potentially reducing toxic drug exposure. The new strategy primes the tumor with an immune checkpoint inhibitor before using a multikinase inhibitor, enhancing its effectiveness.
Researchers found that low blood oxygen levels correlate with longer time to regain consciousness in patients with severe COVID-19. The study involved 795 patients and found that 72% recovered consciousness before hospital discharge, but 25% took 10 or more days to recover.
A new study finds that mentalizing imagery therapy (MIT) significantly reduces depression, anxiety, and improves well-being in family caregivers. The therapy teaches mindfulness and guided imagery skills to help caregivers better understand their loved ones and manage chronic stress.
Researchers at Massachusetts General Hospital found that using nanomedicines at lower, more frequent doses can normalize the tumor microenvironment and improve cancer treatments. The study showed that this approach can help correct abnormalities that protect tumors and improve blood vessel function and immune activation within a tumor.
A pilot study found that asynchronous telehealth visits significantly improved urinary symptoms and reduced incontinence episodes in women with overactive bladder. The treatment kept patients engaged in follow-up care, leading to better compliance with medication and behavioral changes.
Researchers have identified a way to improve bacterial vaginosis treatment by targeting the vaginal microbiome. By analyzing over 1,200 vaginal Lactobacillus genomes and growing a novel strain of Lactobacillus iners in the lab, scientists discovered that this species requires external cysteine sources, which can be blocked using inhibi...
A study found that handheld electrocardiogram (ECG) devices increase the detection of atrial fibrillation in patients aged 85 and older, but not those 65 and older. The compact devices are feasible for screening most patients during primary care visits.
Researchers at Massachusetts General Hospital identified genetic variants in fibrillar collagen genes that increase the risk of spontaneous coronary artery dissection (SCAD), a common cause of fatal heart attacks in young women. The study's findings provide a potential new target for therapies to prevent SCAD.
Scientists have discovered the signature of genes expressed by hematopoietic stem cells that can produce healthy blood cells after being transplanted. This finding could enable scientists to expand these cells outside the body or convert other types of stem cells into functional blood cells.
A new study published in Neurology: Neuroimmunology & Neuroinflammation suggests that some patients with long-COVID experience long-lasting nerve damage due to infection-triggered immune dysfunction. The study found peripheral neuropathy in 59% of patients, with symptoms including weakness, sensory changes, and pain.
New research shows that comprehensive advance care planning effectively improves discussions and documentation, particularly for African American and Hispanic patients. Engaging in ACP conversations empowers patients, meeting them where they are, to make informed decisions about their medical care.
The HEALEY ALS Platform Trial is a groundbreaking approach to drug testing and treatment development for amyotrophic lateral sclerosis (ALS). With over 800 patients enrolled, the trial has already shown promising results, including a favorable active-to-placebo ratio of three to one in favor of receiving an active drug.
Analysis reveals hospitals that publish research studies have better patient outcomes, including lower mortality rates for heart attack, heart failure, and pneumonia. Hospitals with more publications also receive higher patient ratings and are more likely to be recommended by patients.
Researchers found that many newly diagnosed patients with diabetes had less severe blood sugar levels and more severe COVID-19. After hospital discharge, roughly half reverted to normal blood sugar levels, and only 8% required insulin after one year.
Researchers have identified larazotide acetate as a promising treatment for multi-inflammatory syndrome in children (MIS-C), a rare but severe condition. The study showed rapid improvement in symptoms and faster resolution of gastrointestinal issues among children treated with the drug, suggesting its potential as an adjuvant therapy.
A new study finds that the placebo effect activates the same brain regions targeted by brain-stimulation therapy for depression, complicating clinical trial interpretation. The study's findings may offer insights on harnessing the therapeutic potential of the placebo effect.
A new study from Massachusetts General Hospital found that living through the COVID-19 pandemic can lead to brain inflammation and symptoms like fatigue, concentration difficulties, and depression in uninfected people. The research suggests that societal and lifestyle disruptions during the pandemic may trigger this inflammatory response.
A phase 3 trial demonstrates that adding darolutamide to standard therapy prolongs the survival of men with metastatic, hormone-sensitive prostate cancer. The treatment also delays disease progression and reduces need for additional therapies.
Researchers at Massachusetts General Hospital have developed key technologies to enhance acute hospital care at home. These include telemedicine, remote patient monitoring, clinical team coordination, and supply chain management, which have increased inpatient capacity by over 10,000 bed-days.
A new study found that physicians' attitudes about racism's effects on health predict their willingness to intervene when observing racist incidents. Fewer than half of respondents spoke up against racism they observed in the hospital, highlighting the need for training and support.
Scientists have developed a method to maintain human primordial germ cells in culture for at least five months, allowing for the study of their function and development. This breakthrough enables researchers to investigate how exposure to chemicals affects human reproduction and testicular cancer.
A team of researchers has reprogrammed the tumor microenvironment of liver cancer by using mRNA nanoparticles, restoring the function of the p53 master regulator gene. The approach increased antitumor immune responses in hepatocellular carcinoma laboratory models and shows promise for treating HCC and other cancers.
A recent study published in Cell found that T cell responses are still robust against the Omicron variant in most individuals with prior SARS-CoV-2 infection or vaccination, offering protection against severe disease. Booster vaccines can enhance T cell responses, substantially increasing immunity against severe COVID-19.
Combining FDA-approved smoking cessation medications with behavioral support programs significantly increases success rates for quitting tobacco. The review recommends varenicline or combination nicotine replacement therapy as the most effective choices.
Patients with COVID-19 who experienced acute ischemic stroke were more likely to die or have serious complications compared to non-infected stroke patients. The study found that 51% of patients had poor outcomes, including 39.1% death rate within 30 days.